充血微血管阻力预测心肌梗死后临床结局及微血管损伤
本研究汇总五个中心急性心肌梗死血运重建后即刻测量的冠脉血流储备(CFR)与充血微血管阻力(HMR)数据,随访176例患者(中位3.2年),复合终点为死亡和心衰住院。HMR≥3.0 mm Hg cm-1 s预测复合终点(HR 7.0)及微血管损伤优于CFR,且为独立预测因子。
要点
- 急性心梗PCI后即刻测HMR≥3.0 mm Hg cm-1 s可识别微血管损伤高危患者。
- HMR对复合终点及微血管损伤的预测能力优于CFR。
- HMR是临床结局和微血管损伤的独立预测因子,CFR不是。
核心结论
- 急性心梗PCI后即刻测量的HMR以3.0 mm Hg cm-1 s为界值,可识别微血管损伤且临床结局高危的患者。
- HMR对临床结局和微血管损伤的预测优于CFR。
研究设计与样本
- 汇总五个中心急性心梗血运重建后即刻同步测量的冠脉多普勒血流速度和压力数据。
- 纳入176例患者,平均年龄60±10岁,男性140例(80%),STEMI 130例(74%),NSTEMI 46例(26%),中位随访3.2年。
- 其中110例STEMI患者额外行心脏磁共振(CMR)检查。
主要发现
- 复合终点(死亡和心衰住院)发生17例(10%)。
- 预测复合终点的最佳界值:CFR为1.5,HMR为3.0 mm Hg cm-1 s。
- CFR<1.5预测复合终点(HR 3.5;95%CI 1.1至10.8),但不预测各单独组分。
- HMR≥3.0 mm Hg cm-1 s预测复合终点(HR 7.0;95%CI 1.5至33.7)及两个单独组分。
- HMR对微血管损伤的ROC曲线下面积显著大于CFR;HMR为不良临床结局和微血管损伤的独立预测因子,CFR不是。
关键数值与推荐
- CFR预测复合终点的最佳界值为1.5。
- HMR预测复合终点的最佳界值为3.0 mm Hg cm-1 s。
- CFR<1.5预测复合终点HR 3.5(95%CI 1.1至10.8)。
- HMR≥3.0 mm Hg cm-1 s预测复合终点HR 7.0(95%CI 1.5至33.7)。
临床怎么用
- 急性心梗PCI后即刻可测量HMR,以3.0 mm Hg cm-1 s为界值识别微血管损伤和临床结局高危患者。
- HMR预测价值优于CFR,可用于风险分层以考虑辅助治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Early detection of microvascular dysfunction after acute myocardial infarction (AMI) could identify patients at high risk of adverse clinical outcome, who may benefit from adjunctive treatment. Our objective was to compare invasively measured coronary flow reserve (CFR) and hyperaemic microvascular resistance (HMR) for their predictive power of long-term clinical outcome and cardiac magnetic resonance (CMR)-defined microvascular injury (MVI). METHODS: Simultaneous intracoronary Doppler flow velocity and pressure measurements acquired immediately after revascularisation for AMI from five centres were pooled. Clinical follow-up was completed for 176 patients (mean age 60±10 years; 140(80%) male; ST-elevation myocardial infarction (STEMI) 130(74%) and non-ST-segment elevation myocardial infarction 46(26%)) with median follow-up time of 3.2 years. In 110 patients with STEMI, additional CMR was performed. RESULTS: The composite end point of death and hospitalisation for heart failure occurred in 17 patients (10%). Optimal cut-off values to predict the composite end point were 1.5 for CFR and 3.0 mm Hg cm-1•s for HMR. CFR <1.5 was predictive for the composite end point (HR 3.5;95% CI 1.1 to 10.8), but not for its individual components. HMR ≥3.0 mm Hg cm-1 s was predictive for the composite end point (HR 7.0;95% CI 1.5 to 33.7) as well as both individual components. HMR had significantly greater area under the receiver operating characteristic curve for MVI than CFR. HMR remained an independent predictor of adverse clinical outcome and MVI, whereas CFR did not. CONCLUSIONS: HMR measured immediately following percutaneous coronary intervention for AMI with a cut-off value of 3.0 mm Hg cm-1 s, identifies patients with MVI who are at high risk of adverse clinical outcome. For this purpose, HMR is superior to CFR.
引用
- de Waard GA, Fahrni G, de Wit D, et al. Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction. Heart. 2017. PMID: 28663361. doi:10.1136/heartjnl-2017-311431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。